(Q44938364)

7 December 2017

title

Protective effects of N-acetyl-L-cysteine on the reduction of dopamine transporters in the striatum of monkeys treated with methamphetamine (English)

1 reference

7 December 2017

0 references

1 reference

0 references

1 reference

Kenji Hashimoto

1

1 reference

7 December 2017

Hideo Tsukada

2

1 reference

7 December 2017

Shingo Nishiyama

3

1 reference

7 December 2017

Dai Fukumoto

4

1 reference

7 December 2017

Takeharu Kakiuchi

5

1 reference

7 December 2017

Eiji Shimizu

6

1 reference

7 December 2017

Masaomi Iyo

7

1 reference

7 December 2017

language of work or name

English

0 references

publication date

1 November 2004

1 reference

7 December 2017

published in

Neuropsychopharmacology

1 reference

7 December 2017

volume

29

1 reference

7 December 2017

issue

11

1 reference

7 December 2017

page(s)

2018-2023

1 reference

Dopamine- or L-DOPA-induced neurotoxicity: the role of dopamine quinone formation and tyrosinase in a model of Parkinson's disease

7 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300512

Therapeutic potential of N-acetylcysteine in age-related mitochondrial neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300512

Speed kills: cellular and molecular bases of methamphetamine-induced nerve terminal degeneration and neuronal apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300512

Dopamine receptor binding: Differentiation of agonist and antagonist states with 3H-dopamine and 3H-haloperidol

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300512

Effect of antioxidant N-acetyl-L-cysteine on behavioral changes and neurotoxicity in rats after administration of methamphetamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300512

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300512

Simplified reference tissue model for PET receptor studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300512

Dizocilpine and reduced body temperature do not prevent methamphetamine-induced neurotoxicity in the vervet monkey: [11C]WIN 35,428 - positron emission tomography studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300512

Long-term methamphetamine-induced decreases of [(11)C]WIN 35,428 binding in striatum are reduced by GDNF: PET studies in the vervet monkey

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300512

Ketamine increases the striatal N-[11C]methylspiperone binding in vivo: positron emission tomography study using conscious rhesus monkey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300512

N-acetylcysteine increases liver blood flow and improves liver function in septic shock patients: results of a prospective, randomized, double-blind study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300512

Methamphetamine-related psychiatric symptoms and reduced brain dopamine transporters studied with PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300512

Association of dopamine transporter loss in the orbitofrontal and dorsolateral prefrontal cortices with methamphetamine-related psychiatric symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300512

Roles of endogenous glutathione levels on 6-hydroxydopamine-induced apoptotic neuronal cell death in human neuroblastoma SK-N-SH cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300512

Cytotoxic and genotoxic potential of dopamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300512

Brain activation study by use of positron emission tomography in unanesthetized monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300512

Comparative effects of methamphetamine and nicotine on the striatal [(11)C]raclopride binding in unanesthetized monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300512

Ketamine alters the availability of striatal dopamine transporter as measured by [(11)C]beta-CFT and [(11)C]beta-CIT-FE in the monkey brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300512

Isoflurane anesthesia enhances the inhibitory effects of cocaine and GBR12909 on dopamine transporter: PET studies in combination with microdialysis in the monkey brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300512

Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300512

Molecular mechanisms of N-acetylcysteine actions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300512

Methamphetamine neurotoxicity: necrotic and apoptotic mechanisms and relevance to human abuse and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300512

Role of dopamine transporter in methamphetamine-induced neurotoxicity: evidence from mice lacking the transporter.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300512

7 January 2021

Increased methamphetamine neurotoxicity in heterozygous vesicular monoamine transporter 2 knock-out mice.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300512

7 January 2021

Methamphetamine-induced dopaminergic neurotoxicity: role of peroxynitrite and neuroprotective role of antioxidants and peroxynitrite decomposition catalysts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300512

7 January 2021

Dopamine quinone formation and protein modification associated with the striatal neurotoxicity of methamphetamine: evidence against a role for extracellular dopamine.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300512

7 January 2021

Reduced striatal dopamine transporter density in abstinent methamphetamine and methcathinone users: evidence from positron emission tomography studies with [11C]WIN-35,428.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300512

7 January 2021

N-Acetylcysteine treatment to prevent the progression of multisystem organ failure: a prospective, randomized, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300512

7 January 2021

Brain dopamine neurotoxicity in baboons treated with doses of methamphetamine comparable to those recreationally abused by humans: evidence from [11C]WIN-35,428 positron emission tomography studies and direct in vitro determinations.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300512

7 January 2021

Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300512

7 January 2021

Striatal dopamine nerve terminal markers in human, chronic methamphetamine users

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300512

7 January 2021

Identifiers

DOI

10.1038/SJ.NPP.1300512

1 reference

Dimensions Publication ID

7 December 2017

1041763710

0 references

1 reference